First Patient Treated in Myra Vision's U.S. ADAPT Clinical Study for Glaucoma
PR Newswire —
Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas The IDE study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System CAMPBELL, Calif., Jan. 26, 2026 /PRNewswire/ -- Myra Vision, a Shifamed...